Accelerating Drug Discovery Grant
Funding Amount
Not stated
Deadline
Deadline not published
Grant Type
Foundation
Overview
Funder: The Association for Frontotemporal Degeneration (AFTD) and Alzheimer's Drug Discovery Foundation (joint effort)
Program Status: Active
Geographic Scope: Not specified
Focus Areas:
- Drug discovery and therapeutic development for FTD
- Translational research
- Gene therapy approaches
Overview:
The Accelerating Drug Discovery Grant is a collaborative funding program between AFTD and the Alzheimer's Drug Discovery Foundation designed to support researchers in developing therapeutic strategies and drug candidates for FTD.
Notable Recipient Example:
- Thomas Kukar, PhD - Received 2017 Accelerating Drug Discovery Grant (building on 2014 Pilot Grant) to develop therapeutic strategies to replace granulins and explore gene therapy approaches for progranulin-related FTD
Address: 2700 Horizon Drive, Suite 120, King of Prussia, PA 19406
What The Association for Frontotemporal Degeneration actually gave
Source: IRS Form 990, 2025
- Grants in 2025
- 6
- Total given
- $1.55M
- Median grant
- $175K
- Range
- $100K–$700K
- By dollars: New York 45%, Pennsylvania 19%, Missouri 15%. Top recipient cities: New York, NY; King of Prussia, PA; St. Louis, MO.
- 0% of grants with a stated purpose were for general or operating support.
Example grants
Alzheimer's Drug Discovery Foundation · New York, NY
Addf/aftd drug discovery program and treat treatftd therapeutic initiative
$700K
The FTD Disorders Registry · King of Prussia, PA
Ftd patient registry
$287K
Washington University in St Louis · St Louis, MO
Pathways for hope pilot grant
$230K
Stanford University · Stanford, CA
Holloway postdoctoral fellowship
$120K
University of Texas at Austin · Austin, TX
Well-being in ftd pilot grant
$110K
Focus Areas & Funding Uses
Fields of Work
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Well-Being in FTD Pilot Grant
The Association for Frontotemporal Degeneration
Amount
Varies
Deadline
Deadline not published
Pilot Projects to Enhance the Human Virome Program (R03 Clinical Trials Not Allowed)
National Institutes of Health
Amount
$50,000 - $100,000
Deadline
November 10, 2026
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
National Institutes of Health
Amount
$40,000,000 total
Deadline
November 10, 2026
DoW Vision, Translational Research Award
Defense Health Agency Contracting Activity - DHACA
Amount
$1,600,000 total
Deadline
November 12, 2026
ROSES 2025: C.2 Solar System Science
NASA Headquarters
Amount
Varies
Deadline
November 12, 2026
DoW Vision, Investigator-Initiated Research Award
Defense Health Agency Contracting Activity - DHACA
Amount
$4,400,000 total
Deadline
November 12, 2026
Ready to apply for Accelerating Drug Discovery Grant?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Accelerating Drug Discovery Grant. Now let's win it.